AMPG vs SOTK

AMPG's deterministic health scores signal severe financial distress: the Piotroski F-Score of 1/9 indicates extreme weakness in operational and financial health, while the absence of an Altman Z-Score raises unquantified bankruptcy risk. Despite a remarkable 115% YoY revenue growth and a recent positive earnings surprise, the company operates at a significant loss with negative ROE (-27.13%) and ROA (-13.23%), and its gross margin (23.07%) is insufficient to offset deep operating and net losses. The stock trades at a premium valuation (P/S of 2.86, forward P/E of 4.74) despite negative profitability, suggesting high growth expectations that may not be sustainable. Analysts' target price of $9.00 reflects optimism, but with only one analyst covering the stock and no insider buying, conviction remains low.

SOTK exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. The stock is currently trading at $4.18, a substantial premium over both its Graham Number ($1.66) and estimated Intrinsic Value ($2.94). While the company maintains a strong liquidity position with a current ratio of 4.24, negative year-over-year revenue growth (-3.60%) suggests a lack of organic expansion. The combination of bearish insider activity and a 0/100 technical trend further reinforces a negative outlook.